These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 15954872)
21. The effects of hormone replacement therapy and resistance training on spine bone mineral density in early postmenopausal women. Maddalozzo GF; Widrick JJ; Cardinal BJ; Winters-Stone KM; Hoffman MA; Snow CM Bone; 2007 May; 40(5):1244-51. PubMed ID: 17291843 [TBL] [Abstract][Full Text] [Related]
22. Socioeconomic position and lifestyle in relation to breast cancer incidence among postmenopausal women: a prospective cohort study, Denmark, 1993-2006. Larsen SB; Olsen A; Lynch J; Christensen J; Overvad K; Tjønneland A; Johansen C; Dalton SO Cancer Epidemiol; 2011 Oct; 35(5):438-41. PubMed ID: 21227766 [TBL] [Abstract][Full Text] [Related]
23. Changes in the use of hormone replacement therapy in New Zealand from 1991-1997. North FM; Sharples K N Z Med J; 2001 Jun; 114(1133):250-3. PubMed ID: 11453344 [TBL] [Abstract][Full Text] [Related]
24. [Menopause, hormone therapy and self-rated health. A cross-sectional study in Roskilde county in 1998]. Søndergaard KM; Hindsberger C; Toft U; Adser L; Damsgaard JJ; Hvas AC Ugeskr Laeger; 2005 Aug; 167(34):3180-4. PubMed ID: 16117918 [TBL] [Abstract][Full Text] [Related]
25. Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI. Clanget C; Hinke V; Lange S; Fricke R; Botko R; Pfeilschifter J Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):529-33. PubMed ID: 16235155 [TBL] [Abstract][Full Text] [Related]
26. Dimensions of socioeconomic position related to body mass index and obesity among Danish women and men. Groth MV; Fagt S; Stockmarr A; Matthiessen J; Biltoft-Jensen A Scand J Public Health; 2009 Jun; 37(4):418-26. PubMed ID: 19470691 [TBL] [Abstract][Full Text] [Related]
27. Case-control study of postmenopausal hormone replacement therapy and endometrial cancer. Strom BL; Schinnar R; Weber AL; Bunin G; Berlin JA; Baumgarten M; DeMichele A; Rubin SC; Berlin M; Troxel AB; Rebbeck TR Am J Epidemiol; 2006 Oct; 164(8):775-86. PubMed ID: 16997897 [TBL] [Abstract][Full Text] [Related]
29. Urinary hydroxyestrogens and breast cancer risk among postmenopausal women: a prospective study. Wellejus A; Olsen A; Tjonneland A; Thomsen BL; Overvad K; Loft S Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2137-42. PubMed ID: 16172222 [TBL] [Abstract][Full Text] [Related]
30. Effect of the Women's Health Initiative study publication on hormone replacement therapy use among women who have undergone BRCA1/2 testing. Dorval M; Vallée MH; Plante M; Chiquette J; Gaudet M; Simard J Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):157-60. PubMed ID: 17220345 [TBL] [Abstract][Full Text] [Related]
31. ESR1 and APOE gene polymorphisms, serum lipids, and hormonal replacement therapy. Almeida S; Fiegenbaum M; de Andrade FM; Osório-Wender MC; Hutz MH Maturitas; 2006 May; 54(2):119-26. PubMed ID: 16242874 [TBL] [Abstract][Full Text] [Related]
32. Effects of hormone replacement therapy on platelet activation in postmenopausal women. Gu J; Yang D; Wang L; Yin S; Kuang J Chin Med J (Engl); 2003 Aug; 116(8):1134-6. PubMed ID: 12935396 [TBL] [Abstract][Full Text] [Related]
33. Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy. Schuetz F; Diel IJ; Pueschel M; von Holst T; Solomayer EF; Lange S; Sinn P; Bastert G; Sohn C Am J Obstet Gynecol; 2007 Apr; 196(4):342.e1-9. PubMed ID: 17403414 [TBL] [Abstract][Full Text] [Related]
34. Postmenopausal hormone therapy and the risk of cardiovascular disease. Stramba-Badiale M J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340 [TBL] [Abstract][Full Text] [Related]
35. Background factors influencing somatic and psychological symptoms in middle-age women with different hormonal status. A population-based study of Swedish women. Li C; Borgfeldt C; Samsioe G; Lidfeldt J; Nerbrand C Maturitas; 2005; 52(3-4):306-18. PubMed ID: 15967603 [TBL] [Abstract][Full Text] [Related]
36. Vasoactive biomarkers and oxidative stress in healthy recently postmenopausal women treated with hormone replacement therapy. Maffei S; Mercuri A; Prontera C; Zucchelli GC; Vassalle C Climacteric; 2006 Dec; 9(6):452-8. PubMed ID: 17085378 [TBL] [Abstract][Full Text] [Related]
38. Postmenopausal hormone therapy: who now takes it and do they differ from non-users? Taylor AW; MacLennan AH; Avery JC Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):128-35. PubMed ID: 16638035 [TBL] [Abstract][Full Text] [Related]
39. Hormone replacement therapy, reproductive history, and colorectal adenomas: data from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial (United States). Purdue MP; Mink PJ; Hartge P; Huang WY; Buys S; Hayes RB Cancer Causes Control; 2005 Oct; 16(8):965-73. PubMed ID: 16132805 [TBL] [Abstract][Full Text] [Related]
40. Menopause and stroke and the effects of hormonal therapy. Lobo RA Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]